GOOG

290.5

-3.88%↓

GOOG.US

289.33

-3.26%↓

META.US

592.33

-1.84%↓

NFLX

90.85

-2.8%↓

TMUS

211.18

+1.1%↑

GOOG

290.5

-3.88%↓

GOOG.US

289.33

-3.26%↓

META.US

592.33

-1.84%↓

NFLX

90.85

-2.8%↓

TMUS

211.18

+1.1%↑

GOOG

290.5

-3.88%↓

GOOG.US

289.33

-3.26%↓

META.US

592.33

-1.84%↓

NFLX

90.85

-2.8%↓

TMUS

211.18

+1.1%↑

GOOG

290.5

-3.88%↓

GOOG.US

289.33

-3.26%↓

META.US

592.33

-1.84%↓

NFLX

90.85

-2.8%↓

TMUS

211.18

+1.1%↑

GOOG

290.5

-3.88%↓

GOOG.US

289.33

-3.26%↓

META.US

592.33

-1.84%↓

NFLX

90.85

-2.8%↓

TMUS

211.18

+1.1%↑

Search

Match Group Inc

Suletud

SektorSideteenused

30.41 -2.53

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

30.07

Max

31.23

Põhinäitajad

By Trading Economics

Sissetulek

49M

210M

Müük

-36M

878M

P/E

Sektori keskmine

12.727

50.178

Aktsiakasum

1.06

Dividenditootlus

2.47

Kasumimarginaal

23.878

Töötajad

2,200

EBITDA

65M

319M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+16.44% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.47%

4.43%

Järgmine tulemuste avaldamine

7. mai 2026

Järgmine dividendimakse kuupäev

21. apr 2026

Järgmine aktsia dividendi kuupäev (ex-date)

7. apr 2026

Turustatistika

By TradingEconomics

Turukapital

-439M

7.2B

Eelmine avamishind

32.94

Eelmine sulgemishind

30.41

Uudiste sentiment

By Acuity

50%

50%

53 / 139 Pingereas Communication services

Match Group Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. märts 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23. märts 2026, 22:55 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23. märts 2026, 21:51 UTC

Omandamised, ülevõtmised, äriostud

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23. märts 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23. märts 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23. märts 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23. märts 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23. märts 2026, 22:42 UTC

Market Talk
Uudisväärsed sündmused

Global Equities Roundup: Market Talk

23. märts 2026, 22:42 UTC

Market Talk
Uudisväärsed sündmused

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23. märts 2026, 22:40 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23. märts 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23. märts 2026, 22:22 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23. märts 2026, 22:21 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23. märts 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23. märts 2026, 22:19 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23. märts 2026, 22:18 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23. märts 2026, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23. märts 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23. märts 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. märts 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23. märts 2026, 21:32 UTC

Tulu

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23. märts 2026, 21:10 UTC

Uudisväärsed sündmused

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23. märts 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23. märts 2026, 20:50 UTC

Market Talk
Tulu
Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Match Group Inc Prognoos

Hinnasiht

By TipRanks

16.44% tõus

12 kuu keskmine prognoos

Keskmine 36.33 USD  16.44%

Kõrge 49 USD

Madal 31 USD

Põhineb 14 Wall Streeti analüütiku instrumendi Match Group Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

4

Osta

10

Hoia

0

Müü

Sentiment

By Acuity

53 / 139 Pingereas Sideteenused

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Match Group Inc

Match Group, Inc. engages in the provision of dating products. Its portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and Hakuna, as well as a various other brands, each built to increase users' likelihood of connecting with others. Its services are available in over 40 languages to users worldwide. The company was incorporated in 1986 and is based in Dallas, Texas.
help-icon Live chat